Stock exchanges
Middlefield Banc Corp., a bank holding company headquartered in Middlefield, Ohio, has filed a Form 8-K with the US Securities and Exchange Commission (SEC). The filing, dated July 28, 2025, reports that the company intends to use materials furnished in one or more meetings with investors and analysts during the
Securities law
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, has regained compliance with Nasdaq's minimum $1 bid price requirement after previously failing to meet the requirement. This development was confirmed in a July 23, 2025 letter from the Listing Qualifications staff of The NASDAQ Stock Market LLC. The matter relating to
Securities law
Wag! Group Co., a pet services company, has filed for Chapter 11 bankruptcy protection and received a notice from the Nasdaq Stock Market LLC to delist its common stock and warrants. On July 23, 2025, the company received a written notice stating that its securities will be delisted due to
Financial statements
Solarius Capital Acquisition Corp. announced the consummation of its initial public offering (IPO) and private placement results on July 17, 2025. The company raised $176.5 million in gross proceeds through the sale of 17,250,000 units at $10.00 per unit, with 450,000 units sold to Solarius
Securities law
Ikena Oncology, Inc., a biopharmaceutical company focused on developing innovative cancer therapies, has announced a significant corporate restructuring. As part of this effort, the company will undergo a 1-for-12 reverse stock split, reducing the number of outstanding shares from approximately 48.2 million to 4 million. The reverse stock split
Securities law
MainStreet Bancshares, Inc., a Virginia-based financial services company, has announced a cash dividend to its common shareholders. On July 23, 2025, the Board of Directors declared a $0.10 per share dividend, payable on August 13, 2025, to shareholders of record on August 6, 2025. This decision was made after
Securities law
Oncolytics Biotech, a leading clinical-stage company specializing in immunotherapy for oncology, has successfully regained compliance with the minimum bid price requirement under Nasdaq's Listing Rule 5550(a)(2). The company, which had previously failed to maintain a minimum bid price of $1.00 per share for 30 consecutive
Financial markets
Lulus, a California-based luxury fashion brand for women, has regained compliance with the minimum bid price requirement for listing on the Nasdaq Capital Market. The company announced that it had met the requirement of maintaining a minimum closing bid price of $1.00 or more for at least 10 consecutive
Securities law
Oncolytics Biotech Inc., a clinical-stage biotechnology company specializing in immunotherapy for oncology, has regained compliance with the minimum bid price requirement under Listing Rule 5550(a)(2) of The Nasdaq Stock Market LLC. This compliance was achieved after the closing bid price of the company's common shares remained
Securities law
Third Harmonic Bio, Inc. has filed a Current Report on Form 8-K with the U.S. Securities and Exchange Commission announcing its voluntary liquidation and dissolution. The company's stockholders approved the dissolution at the Annual Meeting on June 5, 2025. The company intends to file a Form 25
Financial markets
SciSparc Ltd., a clinical-stage pharmaceutical company, has regained compliance with Nasdaq's Listing Rule 5550(a)(2) after maintaining a minimum bid price of $1.00 per share for 10 consecutive business days. This milestone was confirmed by a written notice from The Nasdaq Stock Market LLC on July
Financial markets
Inspira Technologies, a pioneer in life-support and diagnostic technologies, has regained compliance with Nasdaq Listing Rule 5550(a)(2) concerning the minimum bid price requirement. The company's shares have maintained a minimum bid price of $1.00 per share for 10 consecutive business days, satisfying the requirements for
